FDA Investigator Jay V Jariwala
Jay V Jariwala has inspections in 3 countries as of 01 Aug 2023. Jay V Jariwala has collaborated with a combined 822 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
3
Last Inspection Date:
01 Aug 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
India,
United States of America,
China
Co-Investigator(s):
A Williams,
Aimee J Edwin,
Alicia M Mozzachio,
Alison A Nicoli,
Alison A Stone,
Annabelle Crusan, D,VM,
April L Young,
Azza Talaat,
Benjamin W Anderson,
Billi Jom Johnson,
Demetria L Lueneburg,
Douglas W Atkins,
Gwyn G Dickinson,
Harperd,
James A Beaulieu,
Jose E Melendez, DDC,
Joseph M Edwin,
Justin A Boyd,
Kellie L Thommes, RN,
Kham Phommachanh,
Kimberly Lewandowski Walker,
Linda F Murphy,
Makini Cobourne Duval, PhD,
Marie F Morin,
Marissa S Henning,
Marissa S Steinhagen,
Massoud Motamed,
Muralidhara B Gavini, PhD,
Nicole C Victoria, PhD,
Norman Wong,
Pankaj H Amin,
Parul M Patel,
Paul A Bonneau,
Peter E Baker,
Rafael E Arroyo,
Ralph Jerndal,
Robert J Martin,
Sharon L Matson,
Susan A Atcher,
Susan M Atcher,
Susan M Matthias,
Thomas J Arista,
Timothy G Philips,
Tony T Yang,
Walden H Lee,
Yehualashet A Gessesse
Jay V Jariwala's Documents
Publish Date | Document Type | Title |
---|---|---|
August, 2017 | FDA 483 | Emcure Pharmaceuticals Limited - Form 483, 2017-08-17 |
November, 2015 | FDA 483 | Beijing Taiyang Pharmaceutical Industry Co. Ltd. - Form 483, 2015-11-19 |
April, 2012 | FDA 483 | Boston Scientific Corporation - Form 483, 2012-04-16 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more